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Opium use has been associated with higher risk of cancers of the esophagus, bladder, larynx, and lung; however, no previous
study has examined its association with gastric cancer. There is also little information on the associations between hookah
(water pipe) smoking or the chewing of tobacco products and the risk of gastric cancer. In a case-control study in Golestan
Province of Iran, we enrolled 309 cases of gastric adenocarcinoma (118 noncardia, 161 cardia and 30 mixed-location adeno-
carcinomas) and 613 matched controls. Detailed information on long-term use of opium, tobacco products and other covari-
ates were collected using structured and validated lifestyle and food frequency questionnaires. Odds ratios (ORs) and 95%
confidence intervals (95% CIs) were obtained using conditional logistic regression models. Opium use was associated with an
increased risk of gastric adenocarcinoma, with an adjusted OR (95% CI) of 3.1 (1.9–5.1), and this increased risk was apparent
for both anatomic subsites (cardia and noncardia). There was a dose-response effect, and individuals with the highest cumula-
tive opium use had the strongest association (OR: 4.5; 95% CI: 2.3–8.5). We did not find a statistically significant association
between the use of any of the tobacco products and risk of gastric adenocarcinoma, overall or by anatomic subsite. We
showed, for the first time, an association between opium use and gastric adenocarcinoma. Given that opium use is a tradi-
tional practice in many parts of the world, these results are of public health significance.
Gastric cancer is the second most common cancer in men and
the fourth most common cancer in women in developing coun-
tries.1 The striking geographical variation in gastric cancer inci-
dence and mortality, as well as the signiﬁcant changes in rates
over time and among migrants, suggest a strong role for environ-
mental and life style factors in its pathogenesis.2 Previous studies
have identiﬁedHelicobacter pylori infection and cigarette smoking
as risk factors associated with higher risk of gastric cancer while
higher intake of fruits and vegetables and the use of refrigerators
have shown an inverse association with gastric cancer risk.2–8
Regular use of opium has been reported to be associated
with increased risk of several cancers, including esophageal
cancer,9–11 laryngeal cancer,12 bladder cancer13–15 and lung
cancer,16 but to our knowledge, no epidemiologic studies of
opium use and gastric cancer have been published. About
0.3%–0.5% of the world’s population in the 15–64-year-old
age group, between 12 and 21 million people, used opiates at
least once in 2009.17 Opium is traditionally used in many
South-Central Asian countries, especially Iran, Pakistan, Af-
ghanistan and India, as well as in some areas of South-East
Asia. These are also areas with some of the highest rates of
gastric cancer incidence and mortality in the world. In many
of these areas, hookah (water-pipe) use is also a widely prac-
ticed social habit,18 and it is estimated that 100 million people
across the world smoke hookah.19 Although numerous studies
have examined the association between cigarette smoking and
gastric cancer,20–22 much less is known about the associations
of other types of tobacco use, such as smoking hookah or
chewing tobacco, and this malignancy. These products have
been shown to increase the risk of lung23 and esophageal can-
cer,10,24 and a World Health Organization Study Group has
recommended more research on them,18 as the amount of
evidence on their health effects remains modest.23
In Iran, gastric cancer has the highest incidence among all
cancers, excluding skin cancers,25 but it shows geographical
variation in incidence across the country, with northwestern
and northeastern Iran having the highest rates.3 In the
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northeast of Iran, 17% of individuals above the age of 40
have experienced opium use, and about 7.6% have ever used
nass (a chewing product containing tobacco, ash and lime).26
We recently collected detailed data on the use of opium and
several types of tobacco (cigarettes, hookah and nass) in a case–
control study of gastric cancer in Golestan Province in north-
eastern Iran. The purpose of our analysis is to examine the
association between these exposures and gastric cancer.
Material and Methods
Case and control selection
Cases were enrolled from December 2004 to December 2011,
in Atrak Clinic, a gastroenterology specialty clinic in Gonbad
City, the largest city in Golestan Province. Case selection
methods were similar to those in a previous case–control study
of esophageal cancer in this area.10 In brief, local physicians
referred patients suspected of having upper gastrointestinal
(GI) tract diseases to Atrak Clinic, where they underwent
upper GI endoscopy. Biopsy samples of any mass or lesions
were taken and reviewed by expert pathologists at the Diges-
tive Disease Research Center, Tehran University of Medical
Sciences. Patients with pathology reports of adenocarcinoma
of the stomach were asked to participate in our study.
For each case, we tried to select two age, sex and neigh-
borhood-matched controls from 50,045 healthy subjects, aged
40–75 years, who were enrolled in the Golestan Cohort Study
between January 2004 and June 2008.26 Cohort participants
completed general and food frequency questionnaires similar
to those for cases (see below), and gave blood, hair and nail
samples. We have previously shown that controls from this
cohort correctly reﬂect opium use in the neighborhoods of
cancer cases, and compared to hospital controls, they provide
more accurate estimates of cancer risks due to opium or
tobacco consumption.11
The study protocol was reviewed and approved by the
Institutional Review Boards of the Digestive Disease Research
Center of Tehran University of Medical Sciences, the US
National Cancer Institute (NCI), and International Agency
for Research on Cancer (IARC). A written informed consent
was obtained from each study participants.
Questionnaires and physical examination
We administered two structured questionnaires, a general
questionnaire and a food frequency questionnaire. The gen-
eral questionnaire included detailed information on age, sex,
ethnicity, place of residence, education, ownership of applian-
ces and property (as indicators of socioeconomic status), and
other potential confounders of interest. The food frequency
questionnaire was previously validated in the Golestan popu-
lation27 and was used in our study to extract data for fruit
and vegetable consumption.
Our general questionnaire included extensive and detailed
questions about the exposures of interest in our study, i.e.,
opium, cigarettes, hookah and nass. Our previous studies have
shown that the responses of individuals in this population to
questions regarding opium and tobacco use are reliable and
valid.28 Lifelong history of use was asked, including all starting
and stopping ages, and the average amount of use in each pe-
riod. Thus, the questionnaires allowed for multiple rounds of
using and stopping and different amounts of use in each pe-
riod. Ever users of opium or tobacco products were deﬁned as
those reporting consuming the product at least once a week
for a minimum of 6 months. Opium consumption was
recorded using the local unit of nokhod per day, each nokhod
being equal to 0.2 g, and lifetime use was calculated as
nokhod-years (nokhod used per day 3 duration of use in
years). For cigarette smoking, pack-years were calculated, and
for hookah and nass a similar measure was calculated using
frequency of use per day 3 duration of use in years.
Biological sample collection
Each case provided 10 ml of venous blood: 5 ml in EDTA
anticoagulant was stored as whole blood at 280C, and 5 ml
without anticoagulant was centrifuged and the serum was
stored at 280C. Controls provided a 10 ml sample of ve-
nous blood which was centrifuged and aliquoted into 500 ml
straws (eight straws of plasma, four straws of buffy coat and
two straws of red blood cells) and stored at 280C. Serum
samples of cases and plasma samples of controls were used
to determine seropositivity against CagA antigens of
H. pylori. CagA analysis was performed in the German Can-
cer Research, Center, Heidelberg, Germany, using previously
published method.29
Statistical analysis
The primary prespeciﬁed null hypothesis was that opium use
was not associated with odds of gastric cancer. The large ma-
jority of the cases 276 (83.4%) had two controls, but we were
not able to match two controls to each case, because the
cohort study participants, from whom controls were selected,
What’s new?
Opium use has been associated with higher rates of various cancers, and this study is the first to look at the relationship
between opium use and gastric cancer risk. The authors collected information from 309 gastric cancer cases and almost twice
that many age, gender and neighborhood-matched controls about their opium use, among other lifestyle factors. Those that
had ever used opium were three times more likely to have contracted gastric cancer. They found no association between
gastric cancer and cigarette smoking, which is a more well-known risk factor.
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